Literature DB >> 20056728

Developing computational model-based diagnostics to analyse clinical chemistry data.

Daniël B van Schalkwijk1, Kees van Bochove, Ben van Ommen, Andreas P Freidig, Eugene P van Someren, Jan van der Greef, Albert A de Graaf.   

Abstract

This article provides methodological and technical considerations to researchers starting to develop computational model-based diagnostics using clinical chemistry data. These models are of increasing importance, since novel metabolomics and proteomics measuring technologies are able to produce large amounts of data that are difficult to interpret at first sight, but have high diagnostic potential. Computational models aid interpretation and make the data accessible for clinical diagnosis. We discuss the issues that a modeller has to take into account during the design, construction and evaluation phases of model development. We use the example of Particle Profiler development, a model-based diagnostic tool for lipoprotein disorders, as a case study, to illustrate our considerations. The case study also offers techniques for efficient model formulation, model calculation, workflow structuring and quality control.

Mesh:

Year:  2010        PMID: 20056728     DOI: 10.1093/bib/bbp071

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  4 in total

1.  Clustering by plasma lipoprotein profile reveals two distinct subgroups with positive lipid response to fenofibrate therapy.

Authors:  Kees van Bochove; Daniël B van Schalkwijk; Laurence D Parnell; Chao-Qiang Lai; José M Ordovás; Albert A de Graaf; Ben van Ommen; Donna K Arnett
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

2.  Diagnostic markers based on a computational model of lipoprotein metabolism.

Authors:  Daniël B van Schalkwijk; Ben van Ommen; Andreas P Freidig; Jan van der Greef; Albert A de Graaf
Journal:  J Clin Bioinforma       Date:  2011-10-26

3.  Dietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementation.

Authors:  Daniël B van Schalkwijk; Wilrike J Pasman; Henk F J Hendriks; Elwin R Verheij; Carina M Rubingh; Kees van Bochove; Wouter H J Vaes; Martin Adiels; Andreas P Freidig; Albert A de Graaf
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

4.  Lipoprotein metabolism indicators improve cardiovascular risk prediction.

Authors:  Daniël B van Schalkwijk; Albert A de Graaf; Evgeni Tsivtsivadze; Laurence D Parnell; Bianca J C van der Werff-van der Vat; Ben van Ommen; Jan van der Greef; José M Ordovás
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.